Tech and Trends: New Scooters, AI, and Genealogy

This week in tech and business news: Segway unveils new scooters, Nona Biosciences leverages AI for drug discovery, SHEIN supports women, Axiom enhances KYC, and Kaju connects Japanese immigrants to their roots.

Tech and Trends: New Scooters, AI, and Genealogy

It's been a busy week in the world of technology and business! From innovative AI applications in drug discovery to the launch of next-generation electric scooters, there's a lot to unpack. Let's dive into some of the top stories making headlines.

Segway's New eKickScooters Hit the Streets

Segway, the undisputed leader in electric kick-scooter sales with over 13 million units sold worldwide, has just unveiled its third-generation eKickScooters. These aren't just minor upgrades; they're packed with industry-leading tech and performance enhancements. The new models were revealed at Everything Electric in Sydney, showcasing Segway's continued commitment to micromobility solutions.

A person riding a sleek, modern Segway eKickScooter in an urban environment.

These scooters represent a significant leap forward in electric mobility. With improved battery life, enhanced safety features, and a sleeker design, Segway is aiming to solidify its position as the top choice for urban commuters.

AI Revolutionizes Drug Discovery at Nona Biosciences

Nona Biosciences is taking a bold step into the future of biotechnology with the launch of its AI-assisted drug discovery engine, Hu-mAtrIxTM. This cutting-edge platform integrates seamlessly with the company's proprietary Harbour Mice® technology, promising to accelerate the discovery of fully human antibodies across key therapeutic areas.

The goal? To streamline the often lengthy and costly process of drug development. By combining the power of artificial intelligence with proven biotechnological platforms, Nona Biosciences aims to significantly reduce the time and resources required to bring new therapies to market.

A futuristic laboratory scene with scientists working on advanced AI-driven drug discovery technology.

“This is a game-changer for the industry,” says Dr. Anya Sharma, a leading biotech analyst. “The integration of AI into antibody discovery is a crucial step towards more efficient and effective drug development.”

More Headlines: SHEIN, Axiom, and Kaju

Beyond scooters and AI, other notable stories emerged this week:

  • SHEIN and SHEIN Foundation are committing US$700,000 to women's empowerment through a multi-year collaboration with Dress for Success affiliates.
  • Axiom partnered with Know Your Customer to elevate business KYC standards in the digital asset market, integrating real-time verification solutions.
  • Kaju, Inc. launched "Japan Genealogy Connect" to help Japanese immigrants and their descendants discover their ancestral roots, debuting at RootsTech 2025.
A family looking at an old photograph, representing the concept of genealogy and family history research.

These diverse developments highlight the dynamic nature of the global business landscape, with companies innovating and collaborating to address societal needs and technological advancements. Whether it's connecting individuals to their heritage, empowering women in the workplace, or ensuring regulatory compliance in the digital asset market, the week has been filled with impactful initiatives.

Stay tuned for more updates as these stories continue to unfold!

Share this article: